Annual Operating Expenses
$22.83 M
-$6.00 M-20.82%
December 31, 2023
Summary
- As of February 8, 2025, OCX annual total operating expenses is $22.83 million, with the most recent change of -$6.00 million (-20.82%) on December 31, 2023.
- During the last 3 years, OCX annual operating expenses has fallen by -$10.25 million (-30.99%).
- OCX annual operating expenses is now -30.99% below its all-time high of $33.08 million, reached on December 31, 2020.
Performance
OCX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$6.42 M
+$712.00 K+12.46%
September 30, 2024
Summary
- As of February 8, 2025, OCX quarterly total operating expenses is $6.42 million, with the most recent change of +$712.00 thousand (+12.46%) on September 30, 2024.
- Over the past year, OCX quarterly operating expenses has increased by +$1.06 million (+19.69%).
- OCX quarterly operating expenses is now -44.46% below its all-time high of $11.57 million, reached on September 30, 2021.
Performance
OCX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
OCX Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.8% | +19.7% |
| 3 y3 years | -31.0% | -18.6% |
| 5 y5 years | +50.2% | -18.6% |
OCX Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.8% | at low | -18.9% | +189.1% |
| 5 y | 5-year | -31.0% | +2.7% | -44.5% | +189.1% |
| alltime | all time | -31.0% | +553.2% | -44.5% | +189.1% |
OncoCyte Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.42 M(+12.5%) |
| Jun 2024 | - | $5.71 M(+0.4%) |
| Mar 2024 | - | $5.69 M(+15.2%) |
| Dec 2023 | $22.83 M(-20.8%) | $4.94 M(-8.0%) |
| Sep 2023 | - | $5.37 M(-14.7%) |
| Jun 2023 | - | $6.29 M(+0.9%) |
| Mar 2023 | - | $6.23 M(+3.9%) |
| Dec 2022 | $28.83 M(+13.4%) | $6.00 M(-14.5%) |
| Sep 2022 | - | $7.02 M(-11.0%) |
| Jun 2022 | - | $7.89 M(-0.4%) |
| Mar 2022 | - | $7.92 M(-209.8%) |
| Dec 2021 | $25.43 M(-23.1%) | -$7.21 M(-162.3%) |
| Sep 2021 | - | $11.57 M(+6.9%) |
| Jun 2021 | - | $10.82 M(+4.3%) |
| Mar 2021 | - | $10.38 M(+46.5%) |
| Dec 2020 | $33.08 M(+48.8%) | $7.08 M(-22.8%) |
| Sep 2020 | - | $9.18 M(+7.4%) |
| Jun 2020 | - | $8.55 M(+3.3%) |
| Mar 2020 | - | $8.27 M(+10.0%) |
| Dec 2019 | $22.24 M | $7.52 M(+43.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $5.26 M(-3.8%) |
| Jun 2019 | - | $5.46 M(+36.7%) |
| Mar 2019 | - | $4.00 M(-1.2%) |
| Dec 2018 | $15.20 M(-19.3%) | $4.05 M(+33.9%) |
| Sep 2018 | - | $3.02 M(-28.5%) |
| Jun 2018 | - | $4.23 M(+8.2%) |
| Mar 2018 | - | $3.91 M(+0.4%) |
| Dec 2017 | $18.85 M(+69.2%) | $3.89 M(-43.1%) |
| Sep 2017 | - | $6.83 M(+90.4%) |
| Jun 2017 | - | $3.59 M(-20.8%) |
| Mar 2017 | - | $4.53 M(+46.5%) |
| Dec 2016 | $11.14 M(+27.8%) | $3.09 M(+19.8%) |
| Sep 2016 | - | $2.58 M(+2.0%) |
| Jun 2016 | - | $2.53 M(-13.6%) |
| Mar 2016 | - | $2.93 M(-17.2%) |
| Dec 2015 | $8.72 M(+75.3%) | $3.54 M(+47.1%) |
| Sep 2015 | - | $2.41 M(+71.2%) |
| Jun 2015 | - | $1.41 M(+2.8%) |
| Mar 2015 | - | $1.37 M(-8.7%) |
| Dec 2014 | $4.97 M(+42.3%) | $1.50 M |
| Dec 2013 | $3.50 M | - |
FAQ
- What is OncoCyte annual total operating expenses?
- What is the all time high annual operating expenses for OncoCyte?
- What is OncoCyte annual operating expenses year-on-year change?
- What is OncoCyte quarterly total operating expenses?
- What is the all time high quarterly operating expenses for OncoCyte?
- What is OncoCyte quarterly operating expenses year-on-year change?
What is OncoCyte annual total operating expenses?
The current annual operating expenses of OCX is $22.83 M
What is the all time high annual operating expenses for OncoCyte?
OncoCyte all-time high annual total operating expenses is $33.08 M
What is OncoCyte annual operating expenses year-on-year change?
Over the past year, OCX annual total operating expenses has changed by -$6.00 M (-20.82%)
What is OncoCyte quarterly total operating expenses?
The current quarterly operating expenses of OCX is $6.42 M
What is the all time high quarterly operating expenses for OncoCyte?
OncoCyte all-time high quarterly total operating expenses is $11.57 M
What is OncoCyte quarterly operating expenses year-on-year change?
Over the past year, OCX quarterly total operating expenses has changed by +$1.06 M (+19.69%)